SLC2A1 and cancer: In addition, GW501516 increases expression of glucose transporter 1 (Glut-1) and solute carrier family 1 member 5 (SLC1A5), which results in an increased influx of glucose and glutamine in different cancer cell types and subsequently augments cancer cell proliferation [15].